PHGEN II Archive

This page contains information previously put up on the news section of the website or old information regarding PHGEN II. Please do not consult this for current PHGEN II activity.

++++++++++++++++++++++++++++++++

After our workshop at the HTAi Conference in Bilbao on 24 June 2012. We will be organizing another workshop at the EUPHA conference to be held in Malta. Further information can be found here.

++++++++++++++++++++++++++++++++

Interim Reports

Post Steering Committee Meeting, the 3 interim reports of the 3 core pillars namely Quality Assurance, Provision and Use have been made public on the website. Please note that since these reports were internal, all of them contain the guidelines/template for reports within the text as provided by the main coordinator and only provide updates till the assigned date. The 3 interim reports can be found below:

Quality Assurance Interim Report

Provision Interim Report

Use Interim Report

++++++++++++++++++++++++++++++++

The 4th Consortium Meeting of PHGEN II was held from 22-23 September 2011 in Leuven, Belgium. Further details of the meeting can be found here.

++++++++++++++++++++++++++++++++

The Maastricht Molecular Epidemiology Expertise group (M2E2) is offering a challenging five days course (23-27 April 2012) to grasp the essentials of molecular epidemiology. The course brings together the different fields of expertise involved in molecular epidemiological research in a comprehensive and integrated manner. Participants will be confronted with issues ranging from study design to statistical analysis, and interpretation of findings in the context of public health. Focus lies especially on methodological issue, with a variety of disease settings as illustration.

The audience targeted is PhD students and postdoctoral fellows from epidemiology, biology, medicine, statistics, and related fields, as well as at those working in public health, who want to become acquainted with this expanding research area.

For more information and registration please have a look at the website and enclosed flyer.

++++++++++++++++++++++++++++++++

The 2nd Steering Committee Meeting of PHGEN II was held on Friday 1 July 2011 in Luxembourg. Details of the meeting can be found here.

++++++++++++++++++++++++++++++++

The Spanish National Cancer Research Center (CNIO) is organizing the Epidem&OMICS conference which is to be held in Madrid, Spain on 28-29 November 2011. Further details and registration can be found here.

++++++++++++++++++++++++++++++++

The Second International Symposium on Breast Cancer Prevention: epigenome, nutrition and public policy is being held from 9-11 October 2011 and is organized by the International Breast Cancer and Nutrition (IBCN) group initiated at Purdue University, USA in partnership with the French School of Public Health (EHESP) in Rennes, France. Further details of the symposium can be found here.

++++++++++++++++++++++++++++++++

The 3rd PHGEN II Consortium Meeting was held from 14-15 April 2011 at Semmelweis University in Budapest, Hungary. Further information can be found here

++++++++++++++++++++++++++++++++

The Leena Peltonen School of Human Genomics (formerly the Welcome Trust School of Human Genomics), Cambridge UK, is organizing the 4th School of Human Genomics, a 4-day meeting from 21-25 August 2011 that brings together prominent human geneticists and PhD students. The registration deadline is 25 March 2011. Further details about registration can be found here.

++++++++++++++++++++++++++++++++

Public consultation on UK Biobank draft Access procedures


UK Biobank's draft Access Procedures for allowing health researchers to use this unique resource are now online for public consultation. The consultation process closes on Wednesday 6 July 2011.The draft Procedures (and related materials) can be found on the UK Biobank website here.

++++++++++++++++++++++++++++++++

The Institute for Molecular Medicine Finland is organizing a Symposium titled “Global View of Disease Genomics” on 18-19 May 2011 in Helsinki, Finland. The Symposium is in honor of Late Academician of Science, Professor Leena Peltonen-Palotie who unfortunately passed away recently. Further information about registration can be found here.

++++++++++++++++++++++++++++++++

A 2 to 3 year position in Toulouse, France on ethical and societal aspects of high throughput technologies in human genetics (funded on European contracts) is proposed at Inserm, University of Toulouse joint research unit U1027 (Epidemiology and analyses in public health), in the team  "Genomics, biotherapy and public health: interdisciplinary approach" directed by of Anne Cambon-Thomsen. Futher information can be found here.

++++++++++++++++++++++++++++++++

The 2nd PHGEN II Consortium Meeting was held at the Institute for Prospective Technological Studies in Seville, Spain from 14th-15th October 2010 and was a success. Further information about the details of the two day meeting can be found here

++++++++++++++++++++++++++++++++

European Commission launches public consultation on IVD medical devices

The European Commission has launched a public consultation process which aims to provide the Commission with input for the recast of the Directive on In Vitro Diagnostics (IVD). One focus area of the public consultation is the field of genetic tests. In particular direct to consumer services have raised concerns amongst lay people and policy makers. Many of these services currently seem to profit from the "in-house" exemptions of Art 1 (5) of the Directive. The consultation process may lead to a stronger separation between genetic tests and other medical devices whereas the life sciences increasingly advocate for an integration of genome-based information and other medical information. Policies directed towards direct to consumer services could potentially have negative side effects on other genome-based services and Public Health. The DG SANCO has provided more information on the public consultation on its website. The deadline is September 15th 2010. Further information can be found here.

++++++++++++++++++++++++++++++++

Expert Workshop held: data protection issues in biobanking

On Jan. 28th, the Public Health Genomics European Network hosted together with the Institute for Prospective Technology Studies (JRC-IPTS) and the BBMRI project an expert workshop in Sevilla / Spain which addressed data protection issues in biobanking. The workshop addressed domains related to data protection, legal regulations for samples and the role of ethics committees. Experts from academia, industry and the European Commission shared their views and discussed the future of biobanking in Europe. Data protection and the protection of privacy have been highlighted as key elements which secure the trust of citizens in this process. More information and a summary of the meeting will become available soon. The JRC-IPTS will also publish a report in the next weeks which demonstrates different options for future collaborations in European biobanking.

++++++++++++++++++++++++++++++++

Press Notification

With a heavy heart we want to inform that Professor Leena Peltonen-Palotie, MD, PhD, Head of Human Genetics at the Wellcome Trust Sanger Institute passed away on 11 March 2010 at her home in Finland. She had been one of the founders of P3G and also had been partner in PHGEN I. She always supported our work. Condolences to her near and dear ones. Further information can be found from here

++++++++++++++++++++++++++++++++

WP5 Kick-off Meeting

Work Package 5 of PHGEN II met on 22nd December 2009. The minutes of that meeting can be found here.

++++++++++++++++++++++++++++++++ 

APOGEE-Net/CanGčneTest network fellowships
is offering several training fellowships:

- to students at the master (2 years), doctoral (3 years), or postdoctoral
(2 years) levels; additional information can be found here.

- and also one year training fellowships to students already enrolled at the master, doctorate, or post-doctorate. Additional information can be found here.

++++++++++++++++++++++++++++++++

+++   NEWS   ++   ACTIVITIES  +++

PHGEN I ended in March 2009. PHGEN II continued at Maastricht University and was led by Prof. Dr. Angela Brand. PHGEN II has officially ended on 30 November 2012 with the reporting period ending on 30 January 2013.

++++++++++++++++++++++++++++++++

Follow us on TWITTER!

++++++++++++++++++++++++++++++++

PHGEN II as a Success Story, Biobanks and Personalized Medicine

PHGEN II has been selected as one of the success stories funded by the EU heath programs. The detailed report can be found here. PHGEN II has also been mentioned in the report of the European Commission expert group on biobanks and can be found here. Further our project has been pubished in the European Science Foundation's 'Personalised Medicine for the European Citizen' and can be found here.

++++++++++++++++++++++++++++++++

Meeting of European Alliance for Personalised Medicine

Commissioner Dalli (speech) and Cyprus Minister Mavroyiannis launched in Brussels on 18 September 2012 the manifesto by the newly-formed European Alliance for Personalised Medicine (EAPM), which brings together patient groups, academia, health professionals and industry, as well as the European Commission and the European Medicines Agency. This news has been covered by APM Health and the European Parliament Magazine. Click here for the picture of our PHGEN coordinator discussing with Commissioner Dalli.

++++++++++++++++++++++++++++++++

Guidelines Published

During the final meeting in April 2012 in Rome, the PHGEN II European Best Practice Guidelines for Quality Assurance, Provision and Use of Genome-based Information and Technologies have been officially endorsed as the "Declaration of Rome 2012" by the  European Member States as well as European key Institutions and Organizations such as EMA. The "Declaration of Rome 2012" has been published in the Journal "Drug Metabolism and Drug Interactions". It can be downloaded for free at the journal website here. Also a related editorial has also been published in the same journal which can be found at the journal website here. The "Declaration of Rome 2012" is the summary of the European Best Practice Guidelines for Quality Assurance, Provision and Use of Genome-based Information and Technologies produced in the form of 3 individual reports (QA, Provision & Use) by the PHGEN II consortium. These 3 parts can be accees below:

Part I: European Best Practice Guidelines for Quality Assurance of Genome-based Information and Technologies

Part II: European Best Practice Guidelines for Provision of Genome-based Information and Technologies   

Part III: European Best Practice Guidelines for Use of Genome-based Information and Technologies   

++++++++++++++++++++++++++++++++

PHGEN II Extension Granted

Given the success of the project and realizing the deliverables go beyond the current deliverables, the PHGEN II project has been granted a 6 months cost netural extension by the EAHC. Therefore, the project will continue till the 30 November 2012. Originally the project was till 30 May 2012.

++++++++++++++++++++++++++++++++

PHGEN II Final Meeting Rome

The PHGEN II final meeting (endorsement panel) took place in Rome, Italy. It was a success. Further information can be found here.

PHGEN Definitions

PHGEN II has released the definitions list which will be used as the guiding tools for the development of the guidelines. These constitute definitions developed during PHGEN I as well as new definitions. This can be found by clicking the link here.

++++++++++++++++++++++++++++++++

The 3rd and final Steering Committee Meeting of PHGEN II took place on 23 February 2012 in Maastricht, The Netherlands. Further information can be found here.

++++++++++++++++++++++++++++++++

ITFoM is one of six pilot projects in the European Future and Emerging Technologies Flagship scheme. These projects are vying for €1 billion funding from both the European Commission, Member States and other sources over ten years in order to generate a scientific revolution. Further information can be found from here.

++++++++++++++++++++++++++++++++

Old information and news of PHGEN II can be found in the Archives here.

++++++++++++++++++++++++++++++++

Publications

Public Health Genomics Journal
(Journal published in collaboration with GRaPH-Int)

'Public Health Genomics' is the first peer-reviewed international journal to focus on the translation of genome-based knowledge and technologies into public policy, disease prevention and the improvement of population health. It is a multidisciplinary bi-monthly forum containing conceptual and original research articles, editorials, reviews, short communications, country reports, case studies, viewpoints, news and various other features about the nature of public health genomics and related concepts.

For more details please visit http://www.karger.com/phg

PHGEN II is currently also developing a Wiki. This can be accessed here

PHGEN II is coordinated by the Institute for Public Health Genomics (IPHG) at Maastricht University.  The publication list contributed by partners of PHGEN II can be found here.

The IPHG coordinated the bachelor's program Public Health Genomics. The output of the successful course was a report made by the students with supervision from their supervisors. The report can be found here.

Up coming Events

PHGEN II events have now officially ended.